antiretroviral treatments
Gilead’s New Drug Application for Yeztugo accepted by US FDA
The investigational once-weekly oral treatment could be the first long-acting pill for HIV prevention
Gilead Sciences’ Biktarvy granted FDA approval for expanded HIV use
An estimated 1.2 million people in the US are currently living with the virus
Gilead Sciences’ twice-yearly HIV PrEP drug Yeztugo granted FDA approval
More than 100 people in the US were diagnosed with HIV every day in 2023
WHO urges US to ‘reconsider’ withdrawal from global health organisation
President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises
WHO launches $1.5bn emergency appeal to tackle ongoing health crises
The appeal is aimed at providing urgent humanitarian assistance to more than 300 million people
WHO announces priority endemic pathogens for urgent vaccine development
The study identifies the 17 pathogens that regularly cause diseases in communities
Cultivating Interest in Infectious Disease Education at ID Week 2024
IDWeek starts tomorrow, October 16, and Medscape is bringing outcomes and education! We are excited to announce Medscape is presenting six posters that highlight the significant impact of our educational...
WHO announces new mRNA vaccine development initiative against human avian influenza
H5N1 was responsible for 889 cases and 463 deaths across 23 countries from 2003 to 2024
WHO and CEPI call for broader research strategy to prepare for future pandemics
They have highlighted the importance of expanding research to entire families of pathogens
WHO calls for better medicines access to close neurological disorders treatment gap
In 2021, neurological conditions affected more than three billion people worldwide
WHO publishes guidance for HPV vaccine developers to help tackle cervical cancer
In more than nine out of ten cases, the HPV virus leads to cervical cancer, the fourth most common cancer in women globally
WHO publishes new toolkit to improve services for neurological disorders
Neurological conditions such as dementia and stroke were responsible for more than three billion cases globally in 2021